Levocetirizina Doc Generici

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizina Doc Generici, is a second‑generation antihistamine presented as an oral dosage form for systemic use. It is employed to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH USA supplies Levocetirizina Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. All batches are manufactured under EU GMP guidelines and undergo full batch release testing before shipment.

Levocetirizine Dihydrochloride is a second‑generation antihistamine that targets histamine‑mediated allergic conditions.

- Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or other seasonal allergens. - Chronic idiopathic urticaria: diminishes hives and associated itching, improving patient comfort.

Levocetirizine Dihydrochloride may cause adverse reactions, which are categorized by frequency.

Common Side Effects: - Drowsiness: mild sleepiness that may affect alertness. - Headache: transient cranial discomfort. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring immediate attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rapid, life‑threatening allergic response.

When using Levocetirizine Dihydrochloride, consider the following precautions.

- Assess renal function: dose may need adjustment in patients with severe renal impairment. - Monitor for sedation: caution when operating machinery or driving. - Avoid in known hypersensitivity: discontinue if rash or swelling occurs. - Use with caution in pregnancy: discuss risks and benefits with a healthcare professional. - Use with caution in elderly: increased susceptibility to central nervous system effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levocetirizine Dihydrochloride can interact with other medicines; awareness helps manage risk.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase levocetirizine plasma levels. - Other sedating antihistamines: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance drowsiness. - CNS depressants (e.g., benzodiazepines, opioids): may increase sedation. - CYP2D6 substrates (e.g., metoprolol): potential for altered metabolism.